![Clene Inc](/common/images/company/N_CLNN.png)
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- Β via IBN β IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...
LOS ANGELES, March 19, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.061392 | -17.7177489177 | 0.3465 | 0.35 | 0.285 | 320091 | 0.33489519 | CS |
4 | -0.144892 | -33.6958139535 | 0.43 | 0.449399 | 0.285 | 490360 | 0.37785144 | CS |
12 | -0.048792 | -14.6127583109 | 0.3339 | 0.46 | 0.285 | 898709 | 0.35712171 | CS |
26 | -0.064892 | -18.5405714286 | 0.35 | 0.55 | 0.285 | 785259 | 0.39505255 | CS |
52 | -0.524892 | -64.8014814815 | 0.81 | 0.8499 | 0.25 | 696666 | 0.4237317 | CS |
156 | -10.654892 | -97.3938939671 | 10.94 | 17.82 | 0.25 | 569690 | 2.23183959 | CS |
260 | -9.264892 | -97.0145759162 | 9.55 | 17.82 | 0.25 | 514785 | 2.79279232 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.